Cancer Institute

2017 Bon Secours Cancer Institute Summit

September 29, 2017

WE SEE CANCER DIFFERENTLY

The educational activity is Jointly Provided by the Office of Continuing Medical Education of the University of Virginia School of Medicine and Bon Secours Virginia Health System.

PROGRAM DESCRIPTION

Cancer treatment guidelines change rapidly; common treatment one year ago, is no longer standard treatment today. Changes in guidelines are challenging to keep up with as physicians struggle with time constraints and patient load to have opportunities to discuss the latest updates. The standard of care for cancer treatment requires a multidisciplinary approach.

The 2017 Bon Secours Cancer Summit conference is a forum to bridge the gap between independent providers. At this summit a review of updates to NCCN guidelines and changes to treatment recommendations are evaluated with 360° input so many can benefit from research and time spent by individual clinicians. Using a conference to review, evaluate and apply new technology and research results using a multidisciplinary approach allows for

adherence to guidelines and ensures patients receive timely treatment resulting in improved quality of care. The mission to provide Good Help to Those in Need® takes on special meaning in the care of our cancer patients and their families. We strive to provide an environment where healing and hope can flourish.

For the 2017 Bon Secours Cancer Summit, we have chosen the following topics due to the timeliness with what the public is seeing in the media and the need for primary care and medical oncology physicians to have the ability to speak with their patients and answer questions on these topics and to address gaps in the literature: Palliative Care, Cancer Rehabilitation, Cancer Survivorship, Gynecological Oncology, Cancer Research, and Colorectal Cancer.

TARGET AUDIENCEPrimary care physicians, specialists, surgeons, medical oncologists, radiation oncologists, nurse practitioners and other healthcare professionals interested in a deeper knowledge and understanding of the full continuum of cancer care including healthy survivorship.

EDUCATIONAL OBJECTIVESAt the end of the summit, participants will be able to:

� Identify ways that cancer rehabilitation can help their patients

� Describe patient care management through survivorship care plans

� Articulate the role of palliative care for their patients

� Differentiate and discuss the differences in colorectal cancer screening options

� Understand ways to bridge gaps in clinical trial enrollment of the underserved population

� Explain the role the HPV virus plays in cervical cancer

LODGINGDoubleTree by Hilton Hotel Williamsburg 50 Kingsmill Road, Williamsburg, VA, 23185

Please make your reservation directly with hotel by calling 757-220-2500 or by visiting the hotel website at doubletree3.hilton.com/en/hotels/virginia/doubletree-by-hilton-hotel-williamsburg-WBGKRDT/

REGISTRATIONRegistration is free and available online at www.bsvaf.org/CancerSummit. Visit the website and click on “register.” Registration deadline is September 22. There will be no on-site registration

OUR FACULTY

Carrie Riddock, MSPT, CLT-LANA received her master of science in physical therapy from Virginia Commonwealth University/Medi-cal College of Virginia in 1997. Her specialty and passion is cancer rehabilitation. She received her

initial lymphedema training and cancer rehabilita-tion experience while working at Massey Cancer Center. In 2012 she created a cancer rehabilitation continuing education course, which she teaches nationwide through North American Seminars, Inc.

Deborah K. Mayer, PhD, RN, AOCN, FAAN is an advanced practice oncology nurse who has consulted with organizations on issues to improve cancer care and has forty years of cancer nursing practice, education, research, and

management experience. She earned a PhD from the University of Utah, MSN from Yale University, BSN from Excelsior College, nurse practitioner certificate from the University of Maryland, and a diploma from Pennsylvania Hospital School of Nursing. Dr. Mayer is a member of the Adult and Geriatric Health Division in the School of Nurs-ing and the UNC Lineberger Director of Cancer Survivorship.

Thomas Smith, MD is a professor of oncology at the Johns Hopkins University School of Medicine, director of palliative medicine for Johns Hopkins Medicine and the Harry J. Duffey Family Professor of Palliative Care. He received

his MD from Yale Medical School and completed his residency at the University of Pennsylvania and a fellowship in oncology and hematology at the Virginia Commonwealth University School of Medicine. Dr. Smith joined the faculty at Johns Hopkins in 2011.

Christopher McCann, MD re-ceived his doctor of osteopathic medicine degree from University of New England. He completed his residency in obstetrics and gyne-cology at Saint Francis Hospital and Medical Center in Hartford,

Connecticut, and his fellowship in gynecolog-ic oncology at Massachusetts General Hospital. Dr. McCann practices gynecologic oncology and performs major gynecologic surgeries. He focuses on medical and surgical management of patients with ovarian, endometrial, vulvar, and cervical can-cer with an emphasis on minimally invasive tech-niques including laparoscopy and robotic-assisted laparoscopy to enhance traditional gynecologic oncology procedures.

Charles S. Kamen, PhD, Assistant Professor, received his doctor of philosophy degree in clinical psychology from the University of Georgia and a master of public health degree from the University of Rochester. He has a strong

background and training in behavioral medicine, health disparities, and interventions for diverse couples and dyads. He leads the Health Disparities research effort in the University of Rochester NCI Community Oncology Research Program Research Base. Dr. Kamen’s research has focused on factors that lead to health disparities among sexual- and gender-minority populations, specifically disparities in cancer-related health outcomes and psychological distress.

Andrew Vorenberg, MD, FACS received his undergraduate degree from the University of Pennsylvania and his medical degree from the University of Virginia. He completed his general surgery residency at Stamford

Hospital and the University of Virginia, followed by a fellowship in colon and rectal surgery at the Cleveland Clinic in Weston, Florida. Dr. Vorenberg is board certified in colon and rectal surgery as well as general surgery.

PROGRAMFriday, September 29, 2017

7:30–8am Breakfast/Registration & Exhibits Available

8–8:15am Welcome Address and Invocation

William Irvin, Jr., MDMedical Director, Medical Oncology Bon Secours Virginia Director of Clinical Research

8:15–9am Cancer Rehabilitation Carrie Riddock, MSPT, CLT-LANACancer Rehabilitation Specialist Bon Secours Richmond

9–9:45am Survivorship Deborah Mayer, PhD, RN, AOCN, FAANProfessorThe School of NursingThe University of North Carolina at Chapel Hill

9:45–10am Break & Exhibits Available

10–10:45am Palliative Care Thomas Smith, MDDirector of Palliative CareJohns Hopkins Medicine and the Hopkins Sidney Kimmel Comprehensive Cancer Center

10:45–11:30am Gynecological Oncology Christopher McCann, MDGynecology OncologistBon Secours Hampton Roads

11:30am–12pm Lunch (bring back to room)

12–12:45pm HONORED SPEAKER: A Caregiver’s Journey

Joseph Hall

12:45–1:30pm Bridging Gaps: Underserved Population and Clinical Trials

Charles Kamen, PhD, MPHResearch Assistant Professor Department of Surgery University of Rochester Medical Center

1:30–1:45pm Break & Exhibits Available

1:45–2:30pm Colorectal Cancer Andrew Vorenberg, MD, FACSColorectal Surgery Vice Chair of Surgery St. Mary’s Hospital, Richmond, VA

2:30–3:30pm “All Hope Awards”

Closing Remarks

Ryan Stuhlreyer, BS, MBAVP Chronic Conditions Bon Secours Virginia

William Irvin, Jr., MDMedical Director, Medical Oncology Bon Secours Virginia Director of Clinical Research

CME credit will need to be claimed by October 29, 2017.

COURSE DIRECTOR & PLANNING COMMITTEE

William Irvin, Jr, MD (Director) Medical Director, Medical Oncology

Virginia Director of Clinical Research Bon Secours Virginia Health System

Bon Secours Cancer Institute

Beth Brew, MBA Administrative Director, Oncology Services

Bon Secours Richmond

Marylou Anton, MS, RN, OCN Administrative Director, Oncology Services

Bon Secours Hampton Roads

George Parker, MD, FACS General Surgeon

Bon Secours St. Mary’s Hospital

James Pellicane, MD, FACS Breast Surgeon

Virginia Breast Center

Bradley Prestidge, MD, MS Regional Medical Director of

Radiation Oncology Bon Secours Oncology Specialists

Bon Secours Hampton Roads

Ryan Stuhlreyer, BS, MBA Vice President, Chronic Conditions

Bon Secours Virginia

George Bousaba, MD Affiliate & Outreach CME Program Manager

University of Virginia School of Medicine

Kathryn Reid, PhD, APRN, FNP-C, CNL Associate Professor University of Virginia

VISITING FACULTY

Deborah Mayer, PhD, RN, AOCN, FAAN Professor, the School of Nursing

The University of North Carolina at Chapel Hill

Thomas Smith, MD Director of Palliative Care

Johns Hopkins Medicine and the Hopkins Sidney Kimmel

Comprehensive Cancer Center

Charles Kamen, PhD, MPH Research Assistant Professor

Department of Surgery University of Rochester Medical Center

Andrew Vorenberg, MD, FACS Colorectal Surgery

Vice Chair of Surgery St. Mary’s Hospital, Richmond, VA

Joseph Hall Honored Speaker

BON SECOURS FACULTY

Carrie Riddock Cancer Rehabilitation Specialist

Bon Secours Richmond

Christopher McCann Gynecology Oncologist

Bon Secours Hampton Roads

Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Virginia School of Medicine and Bon Secours Cancer Institute.

The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Virginia School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Virginia School of Medicine awards hours of participation (equivalent to AMA PRA Category 1 Credit(s)™ to each non-physician participant who successfully completes this educational activity. Bon Secours Cancer Institute maintains a permanent record of participants who have been awarded CEUs.

Disclosure of Faculty Financial Affiliations

The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.

The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.

All faculty presenters participating in an accredited CME activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.).

The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia. DISCLOSURE OF DISCUSSION OF NON FDA-APPROVED USES FOR PHARMACEUTICAL PRODUCTS AND/OR MEDICAL DEVICES

The following faculty and staff have reported an affiliation to disclose:

James V. Pellicane, MD: the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Agendia; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Focal Therapeutics; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Dune Medical; the following faculty member has disclosed a Commercial Interest in Caris Life Sciences.

Thomas Smith, MD: the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Care Symptom Management; the following faculty member has disclosed Commercial Interest in GEOMC, Inc., Seoul Korea; the following faculty member has disclosed Clinical/Researcher for Neuromodulation.

The following faculty has disclosed no financial relationship or interest with any propriety entity producing healthcare goods or services:

Marylou S. Anton, MSN, RN, OCN*

Beth L. Brew, BSRT (R),(T), MBA*

William Irvin, Jr., MD*

Ryan Stuhlreyer, MBA*

George Parker, MD*

James V. Pellicane, MD*

Bradley Prestidge, MD, MS*

Kathryn Reid, PhD, APRN, FNP*

George Bousaba, MD*

Andrew Vorenberg, MD

Carrie Riddock, MSPT, CLT-LANA

Thomas Smith, MD

Christopher McCann, DO

Joseph Hall, MA

Charles Kamen, PhD

Deborah Mayer, PhD, RN

*denotes Planning Committee

The University of Virginia School of Medicine, as an ACCME provider, requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to clinical use.

The University of Virginia Office of Continuing Medical Education requires that all participants at live CME activities sign attendance sheets daily to confirm participation in the CME activity for that day.

Canc

er In

stitu

te

5875

Bre

mo

Rd,

Sui

te 10

8 R

ichm

ond,

VA

232

26